U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06808880) titled 'EXpanding Prenatal Cell Free DNA Screening Across MoNogenic Disorders (EXPAND)' on Jan. 21.
Brief Summary: The purpose of this research is to develop and validate a single gene Non-Invasive Prenatal Test. The development of this investigational single-gene noninvasive prenatal testing (sgNIPT) for conditions such as cystic fibrosis (CF), spinal muscular atrophy (SMA), Sickle cell disease, alpha thalassemia (a-thalassemia) and beta thalassemia (b-thalassemia) could provide information about the possibility that a child will be born with a serious health condition, in some cases in the absence of reproductive partner screening.
In ord...